pipette
ENEnglish

Low-Intensity Focused Ultrasound of the Amygdala in Depression and Anxiety: A First-in-Human Active-Controlled Trial

A. R. Arulpragasam, M. van 't Wout-Frank, Y. A. Berlow, E. Aiken, A. Gorbatov, R. Van Patten, J. G. Gillotti, H. R. Swearingen, C. R. Faucher, H. Adams, N. C. R. McLaughlin, I. Liberzon, J. Barredo, S. Correia, B. Greenberg, N. S. Philip

PreprintDice ser un gran avanceUso en el mundo real

En palabras de los autores

BackgroundLow-intensity focused ultrasound (FUS) offers a noninvasive method for directly modulating deep brain structures with millimeter-scale precision, potentially addressing a major limitation of existing noninvasive neuromodulation approaches. The amygdala is a key node in affective neurocircuitry and a compelling target for psychiatric intervention. We conducted a first-in-human active controlled trial (NCT05147142) of amygdala-targeted FUS in patients with major depressive disorder, examining safety and target engagement. MethodsTen participants with major depressive disorder completed a single-blind randomized crossover trial with blinded symptom ratings, comparing imaging-guided FUS targeting the right amygdala versus left primary somatosensory cortex as an active control. FUS comprised two 10-minute applications within diagnostic ultrasound safety limits. Primary outcomes were safety and target engagement assessed with BOLD-fMRI during sonication, post-sonication arterial spin labeling (ASL) and resting-state functional connectivity. Secondary and exploratory outcomes included symptom change and imaging-symptom relationships. ResultsNine participants completed both sessions. No serious adverse events occurred; neurological, neuropsychological, and MRI safety assessments were unremarkable. Adverse events were more frequent after amygdala than control sonication (p=0.028); one participant experienced clinical worsening following amygdala sonication and required monitoring. Amygdala sonication produced greater perfusion change in the targeted amygdala compared to the control region (p<0.001), and ipsilateral hippocampus (p<0.001). BOLD-fMRI during sonication demonstrated engagement of ventromedial prefrontal and rostral anterior cingulate regions, while post-sonication resting-state connectivity decreased between basolateral amygdala and sensorimotor regions (corrected ps<0.05). Symptom improvement did not differ between conditions, but exploratory imaging-symptom relationships were significant. Spontaneous reports of calm, clarity, or lightness occurred after amygdala but not control sonication (p<0.001). ConclusionsAmygdala-targeted FUS produced anatomically specific, multimodal evidence of neuromodulation relative to active control, with a manageable safety profile. Convergent target and circuit-level signals support further development of FUS as a precision approach for modulating deep brain targets in psychiatric disorders.

Resultado principalLimitación que admiten los autores

En palabras simples Resumen con IA

Los investigadores probaron ultrasonido enfocado de baja intensidad en la amígdala en diez personas con trastorno depresivo mayor. Compararon la estimulación de la amígdala con un tratamiento de control en un área cerebral diferente en un ensayo cruzado aleatorizado de simple ciego. No ocurrieron eventos adversos graves, aunque los efectos secundarios fueron más comunes después del tratamiento de la amígdala. Las imágenes cerebrales mostraron que el tratamiento de la amígdala cambió el flujo sanguíneo en el área objetivo y regiones conectadas. Los participantes reportaron sentir calma, claridad o ligereza solo después del tratamiento de la amígdala, no después del control.

Escrito por Kimi K2.5 usando solo el abstract de arriba. Jev verificó que cada oración esté respaldada por las oraciones del abstract que cita y eliminó las que no. Pasá el cursor por una oración para ver de dónde sale.

Apareció: lunes, 21 de septiembre. medRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.09.18.26363360